0001683168-23-003492.txt : 20230517
0001683168-23-003492.hdr.sgml : 20230517
20230517133057
ACCESSION NUMBER: 0001683168-23-003492
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
EFFECTIVENESS DATE: 20230517
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sunshine Biopharma, Inc
CENTRAL INDEX KEY: 0001402328
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205566275
STATE OF INCORPORATION: CO
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-481966
FILM NUMBER: 23930975
BUSINESS ADDRESS:
STREET 1: 6500 TRANS-CANADA HIGHWAY
STREET 2: 4TH FLOOR
CITY: POINTE-CLAIRE
STATE: A8
ZIP: H9R 0A5
BUSINESS PHONE: 514-426-6161
MAIL ADDRESS:
STREET 1: 6500 TRANS-CANADA HIGHWAY
STREET 2: 4TH FLOOR
CITY: POINTE-CLAIRE
STATE: A8
ZIP: H9R 0A5
FORMER COMPANY:
FORMER CONFORMED NAME: Mountain West Business Solutions, Inc
DATE OF NAME CHANGE: 20071030
FORMER COMPANY:
FORMER CONFORMED NAME: mountain west business solutions,inc
DATE OF NAME CHANGE: 20070607
D
1
primary_doc.xml
X0708
D
LIVE
0001402328
Sunshine Biopharma, Inc
6500 TRANS-CANADA HIGHWAY
4TH FLOOR
POINTE-CLAIRE
A8
QUEBEC, CANADA
H9R 0A5
514-426-6161
COLORADO
Mountain West Business Solutions, Inc.
Mountain West Business Solutions, Inc
mountain west business solutions,inc
Corporation
true
Steve
N.
Slilaty
6500 Trans-Canada Highway
4th Floor
Point-Claire
A8
QUEBEC, CANADA
H9R 0A5
Executive Officer
Director
Chairman, Chief Executive Officer, and President
Abderrazzak
Merzouki
6500 Trans-Canada Highway
4th Floor
Point-Claire
A8
QUEBEC, CANADA
H9R 0A5
Executive Officer
Director
Chief Operating Officer
Camille
Sebaaly
6500 Trans-Canada Highway
4th Floor
Point-Claire
A8
QUEBEC, CANADA
H9R 0A5
Executive Officer
Chief Financial Officer and Secretary
Rabi
Kiderach
6500 Trans-Canada Highway
4th Floor
Point-Claire
A8
QUEBEC, CANADA
H9R 0A5
Director
David
Natan
6500 Trans-Canada Highway
4th Floor
Point-Claire
A8
QUEBEC, CANADA
H9R 0A5
Director
Andrew
Keller
6500 Trans-Canada Highway
4th Floor
Point-Claire
A8
QUEBEC, CANADA
H9R 0A5
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2023-05-12
false
true
true
false
0
Aegis Capital Corp.
15007
None
None
1345 AVENUE OF THE AMERICAS
27TH FLOOR
NEW YORK
NY
NEW YORK
10105
NY
NEW YORK
false
4996497
4996497
0
false
1
599579
0
0
false
Sunshine Biopharma, Inc
/s/ Steve Slilaty
Dr. Steve N. Slilaty
Chairman, Chief Executive Officer, and President
2023-05-17